nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Vertigo—Prednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Quinidine barbiturate—Syncope—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Eye disorder—Betamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Quinidine barbiturate—Convulsion—Prednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Quinidine barbiturate—Bradycardia—Prednisone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Quinidine barbiturate—Angioedema—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Quinidine barbiturate—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Quinidine barbiturate—Erythema—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Quinidine barbiturate—Erythema—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Quinidine barbiturate—Hallucination—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Quinidine barbiturate—Vertigo—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Syncope—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Syncope—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Quinidine barbiturate—Shock—Prednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Quinidine barbiturate—Convulsion—Triamcinolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Quinidine barbiturate—Myalgia—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Quinidine barbiturate—Eye disorder—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Quinidine barbiturate—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Quinidine barbiturate—Flushing—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Angioedema—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Angioedema—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Quinidine barbiturate—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Quinidine barbiturate—Oedema—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Vertigo—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Vertigo—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Syncope—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Syncope—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Quinidine barbiturate—Shock—Triamcinolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Quinidine barbiturate—Shock—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Mental disorder—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Malnutrition—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Erythema—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Quinidine barbiturate—Convulsion—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Quinidine barbiturate—Convulsion—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Quinidine barbiturate—Myalgia—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Myalgia—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Anxiety—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Anxiety—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Quinidine barbiturate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Quinidine barbiturate—Pain—Prednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Quinidine barbiturate—Vision blurred—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Quinidine barbiturate—Oedema—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Quinidine barbiturate—Oedema—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Shock—Dexamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Shock—Betamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Agitation—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Tachycardia—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Quinidine barbiturate—Angioedema—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Quinidine barbiturate—Vertigo—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinidine barbiturate—Syncope—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinidine barbiturate—Anorexia—Dexamethasone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Anorexia—Betamethasone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Quinidine barbiturate—Pain—Triamcinolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Quinidine barbiturate—Hypotension—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Quinidine barbiturate—Hypotension—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Quinidine barbiturate—Convulsion—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Myalgia—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Arthralgia—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Anxiety—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Quinidine barbiturate—Urticaria—Triamcinolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Quinidine barbiturate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Quinidine barbiturate—Shock—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Pain—Betamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Pain—Dexamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Quinidine barbiturate—Skin disorder—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Quinidine barbiturate—Anorexia—Prednisone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Quinidine barbiturate—Urticaria—Betamethasone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Urticaria—Dexamethasone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Asthenia—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Quinidine barbiturate—Pruritus—Triamcinolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Quinidine barbiturate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Prednisone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Quinidine barbiturate—Rash—Prednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Headache—Prednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Quinidine barbiturate—Constipation—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Quinidine barbiturate—Dizziness—Triamcinolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Quinidine barbiturate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Asthenia—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Asthenia—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Quinidine barbiturate—Pruritus—Betamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Quinidine barbiturate—Pruritus—Dexamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Quinidine barbiturate—Vomiting—Triamcinolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Quinidine barbiturate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Quinidine barbiturate—Rash—Triamcinolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Quinidine barbiturate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Rash—Methylprednisolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Headache—Triamcinolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Headache—Methylprednisolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000969	0.000969	CcSEcCtD
Quinidine barbiturate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000966	0.000966	CcSEcCtD
Quinidine barbiturate—Dizziness—Betamethasone—ankylosing spondylitis	0.000966	0.000966	CcSEcCtD
Quinidine barbiturate—Nausea—Triamcinolone—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Quinidine barbiturate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000954	0.000954	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000948	0.000948	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Quinidine barbiturate—Vomiting—Betamethasone—ankylosing spondylitis	0.000929	0.000929	CcSEcCtD
Quinidine barbiturate—Vomiting—Dexamethasone—ankylosing spondylitis	0.000929	0.000929	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000924	0.000924	CcSEcCtD
Quinidine barbiturate—Rash—Dexamethasone—ankylosing spondylitis	0.000921	0.000921	CcSEcCtD
Quinidine barbiturate—Rash—Betamethasone—ankylosing spondylitis	0.000921	0.000921	CcSEcCtD
Quinidine barbiturate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Quinidine barbiturate—Dermatitis—Betamethasone—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000918	0.000918	CcSEcCtD
Quinidine barbiturate—Headache—Dexamethasone—ankylosing spondylitis	0.000915	0.000915	CcSEcCtD
Quinidine barbiturate—Headache—Betamethasone—ankylosing spondylitis	0.000915	0.000915	CcSEcCtD
Quinidine barbiturate—Asthenia—Prednisone—ankylosing spondylitis	0.000913	0.000913	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Quinidine barbiturate—Pruritus—Prednisone—ankylosing spondylitis	0.0009	0.0009	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000871	0.000871	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00087	0.00087	CcSEcCtD
Quinidine barbiturate—Nausea—Betamethasone—ankylosing spondylitis	0.000868	0.000868	CcSEcCtD
Quinidine barbiturate—Nausea—Dexamethasone—ankylosing spondylitis	0.000868	0.000868	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—ankylosing spondylitis	0.000845	0.000845	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisone—ankylosing spondylitis	0.000841	0.000841	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000841	0.000841	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000841	0.000841	CcSEcCtD
Quinidine barbiturate—Vomiting—Prednisone—ankylosing spondylitis	0.000809	0.000809	CcSEcCtD
Quinidine barbiturate—Rash—Prednisone—ankylosing spondylitis	0.000802	0.000802	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisone—ankylosing spondylitis	0.000802	0.000802	CcSEcCtD
Quinidine barbiturate—Headache—Prednisone—ankylosing spondylitis	0.000797	0.000797	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—ankylosing spondylitis	0.000763	0.000763	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000728	0.000728	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—ankylosing spondylitis	0.000703	0.000703	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—ankylosing spondylitis	0.000676	0.000676	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—ankylosing spondylitis	0.00067	0.00067	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—ankylosing spondylitis	0.00067	0.00067	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—ankylosing spondylitis	0.000666	0.000666	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—ankylosing spondylitis	0.000632	0.000632	CcSEcCtD
